Pioglitazone
Product Images NDC 53002-2757

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 53002-2757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical structure of pioglitazone hydrochloride shown as a two-dimensional molecular diagram indicating its atomic connectivity, including aromatic rings, sulfur, nitrogen, oxygen atoms, and a hydrochloride component.*

FDA Label Image

Figure 1 (Image 2)

A line graph depicting mean values over a period of 26 weeks for four groups: Placebo, 15 mg, 30 mg, and 45 mg. The x-axis represents time in weeks, and the y-axis represents the mean. Each group is represented by different colored and shaped points connected by lines, showing differing trends among the groups over time.*

FDA Label Image

Label Image (Lbl530022757)

Pioglitazone HCl 45 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates 30 tablets in the bottle with directions to take 1 tablet daily or as directed. The label includes the product NDC 53002-2757, and sections for patient and prescriber information, lot number, expiration date, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.